跳至: [中文]   [數字0-9]   [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ] 請輸入前幾個字:

顯示項目9276-9300 / 13423. (共537頁) << < 367 368 369 370 371 372 373 374 375 376 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2019-03	Pharmacokinetic study of amoxicillin in Japanese eel Anguilla japonica by high performance liquid chromatography with fluorescence detection	Aquaculture Reports. 2019 Mar;13:Article number 100184.
2018-10-01	Pharmacokinetic study of florfenicol in Bester sturgeon, a cultured hybrid of Huso huso × Acipenser ruthenus by high performance liquid chromatography equipped with UV detector	Aquaculture. 2018 Oct 1;495:558-567.
2011-05	Pharmacokinetic study with novel anticanacer agents, MPTOB124 and MPTOB214	Drug Metabolism Reviews. 2011 May;43(Suppl. 1):73.
2016-12	Pharmacokinetics and bioavailability of oral single-dose maleic acid in biofluids of Sprague-Dawley rats	Drug Metabolism and Pharmacokinetics. 2016 Dec;31(6):451-457.
2011-06	Pharmacokinetics and dosimetry of (111)In/(188)relabeled PEGylated liposomal drugs in two colon carcinoma-bearing mouse models	Cancer Biotherapy and Radiopharmaceuticals. 2011 Jun;26(3):373-380.
2010-12	Pharmacokinetics and physiologically-based pharmacokinetic modeling of nanoparticles	Journal of Nanoscience and Nanotechnology. 2010 Dec;10(12):8482-8490.
2006-12	Pharmacokinetics of anti-SARS-CoV agent niclosamide and its analogs in rats	Journal of Food and Drug Analysis. 2006 Dec;14(4):329-333.
2008-11	Pharmacokinetics, micro-SPECT/CT imaging and therapeutic efficacy of 188Re-DXR-liposome in C26 colon carcinoma ascites mice model	Nuclear Medicine and Biology. 2008 Nov;35(8):883-893.
2013-08-01	Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression	Cell. 2013 Aug 1;154(3):556-568.
2015-07	Pharmacological induction of human fetal globin gene in hydroxyurea-resistant primary adult erythroid cells	Molecular and Cellular Biology. 2015 Jul;35(14):2541-2553.
2020-06	Pharmacological inhibition of cathepsin S suppresses abdominal aortic aneurysm in mice	European Journal of Vascular and Endovascular Surgery. 2020 Jun;59(6):990-999.
2013-10-11	Pharmacological profiles of oligomerized mu-opioid receptors	Cells. 2013 Oct 11;2(4):689-714.
2020-04	Pharmacological studies of morphine in a novel humanized mu opioid receptor mouse model	FASEB Journal. 2020 Apr;34(S1):Abstract number 02835.
2022-11-17	Pharmacometabolomic study of drug response to antihypertensive medications for hypertension marker identification in Han Chinese individuals in Taiwan	Computational and Structural Biotechnology Journal. 2022 Nov 17;20:6458-6466.
2017-12-28	Pharmacophore anchor models of flaviviral NS3 proteases lead to drug repurposing for DENV infection	BMC Bioinformatics. 2017 Dec 28;18(Suppl. 16):Article number 548.
2023-06	Phase 1 studies of D07001-F4 and D07001-softgel capsule: Oral metronomic gemcitabine in subjects with advanced solid tumors	Journal of Clinical Oncology. 2023 Jun;41(16, Suppl.):Meeting Abstract 3148.
2022-02	Phase 1 study of nanoliposomal irinotecan in combination with trifluridine/tipiracil in refractory solid tumors	Journal of Clinical Oncology. 2022 Feb;40(4, Suppl.):660.
2021-06-12	Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers	Oncoimmunology. 2021 Jun 12;10(1):Article number 1943253.
2021-05	A phase 2 study of liposomal irinotecan with 5-fluorouracil and leucovorin in squamous cell carcinoma of head and neck or esophagus after prior platinum-based chemotherapy or chemoradiotherapy	Journal of Clinical Oncology. 2021 May;39(15, Suppl.):Abstract number 6025.
2022-02-01	A phase 3 randomized, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients (pts) with advanced biliary tract cancer (BTC): TOPAZ-1	Journal of Clinical Oncology. 2022 Feb 01;40(4, Suppl.):378.
2017-09	A Phase 3 Study of nivolumab (Nivo) in previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer: Updated results and subset analysis by PD-L1 expression (ATTRACTION-02)	Annals of Oncology. 2017 Sep;28(Suppl. 5):Meeting Abstract 617O.
2002	Phase I and pharmacokinetic studies of oral thalidomide in advanced hepatocellular carcinoma	International Journal of Cancer. 2002;Suppl. 13:336-337.
2006-11	Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma	Cancer Chemotherapy and Pharmacology. 2006 Nov;58(5):654-664.
2021-03-01	Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors	Scientific Reports. 2021 Mar 1;11:Article number 4834.
2021-04	Phase I dose-escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors	Oncologist. 2021 Apr;26(4):e567-e579.

顯示項目9276-9300 / 13423. (共537頁) << < 367 368 369 370 371 372 373 374 375 376 > >> 每頁顯示[10|25|50]項目